Main > NEUROLOGY. > Multiple Sclerosis > Treatment > Paclitaxel. > Patent. > Claims > Claim 1: Multiple Sclerosis Treat. > Method. Adm. to Patient Paclitaxel. > Claim 2: Systemic Adm. Claim 3: > Oral or IntraVenous Adm. Claim 4: > Dosage: 10-75 mg/m.sup.2 Once > Every 1-4 Weeks. Claim 5: Polymer. > Claim 6: Compn Form: MicroSpheres > Claim 7: Lactic Acid/Glycolic Acid > CoPol. Claim 8: Poly(Caprolactone). > Claim 9: Poly(Lactic Acid). Claim > 10: Caprolactone/Lactic Acid CoPol. > Claim 11: PolyEthylene Glycol. > Claim 12: Ethylene/Vinyl Acetate > CoPol. Claim 13: Paclitaxel Compn

---

CoPol. Claim 13: Paclitaxel Compn's subsections
& Iso-Pr Myristate. Claim 14:

CoPol. Claim 13: Paclitaxel Compn's products
This section has no products